Tag: Ocrevus safety

Infusion reactions are a common side effect of Ocrevus, with 34% to 40% of patients experiencing them in clinical trials. However, a bad reaction to Ocrevus can also involve more severe issues, including life-threatening infections and other serious medical complications.

Ocrevus (ocrelizumab) is a CD20-directed cytolytic antibody used to treat relapsing or primary progressive forms of multiple sclerosis in adults [1.7.1]. Because it works by weakening your immune system, understanding **what to avoid while on Ocrevus** is crucial for your safety and treatment success.